Piotr Czempik: Anti-Xa-Guided Enoxaparin Prophylaxis in Extreme Obesity
Piotr Czempik, Chair of Department of Anesthesiology and Intensive Care at Medical University of Silesia, shared on LinkedIn about recent article he and his colleague co-authored, published in Journal of Transfusion Medicine and Hemostasis, adding:
”How to provide safe and effective antithrombotic prophylaxis in extremely obese patients?
Happy to share our latest case report addressing this challenging critical care issue.
What the paper covers:
Patients >150–200 kg often fail to reach target anti‑Xa levels with standard low-molecular-weight heparin (LMWH) dosing.
In our 200‑kg ICU patient, we implemented a fully individualized strategy using:
- weight‑based enoxaparin dosing
- twice‑daily administration
- serial anti‑Xa monitoring
- additional ROTEM analysis for anticoagulation interpretation
- dynamic dose adjustment to maintain intermediate‑intensity antithrombotic prophylaxis
The result: effective VTE prevention with no bleeding events, demonstrating the value of personalized anticoagulation in this high‑risk population.
Key insight:
An initial enoxaparin dose of 0.3 mg/kg SC BID, followed by anti‑Xa–guided adjustment, may offer a rational and safer approach for ICU patients with extreme obesity.”
Title: Optimizing prophylactic low-molecular-weight heparin anticoagulation in a 200-kg ICU patient: a case report
Authors: Piotr Filip Czempik, Dariusz Bednarski
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 30, 2026, 18:36Amina Ammar: Evaluating Rivaroxaban Dosing Alignment Across Cockcroft–Gault and eGFR Equations
-
Jul 30, 2026, 18:11Tobias Tritschler: Evaluating Timing, Translation and Preparedness in COVID-19 Anticoagulation Management
-
Jul 30, 2026, 16:05Peter Zdziarski: Today is Chronic Disease Awareness Day
-
Jul 30, 2026, 15:50Ahmad Gharehbaghian: New Blood Transfusion Centers Open in Iran
-
Jul 30, 2026, 15:32Can We Better Protect Hospitalized Patients With Obesity From Venous Thromboembolism? – RPTH Journal
-
Jul 30, 2026, 15:162025 Platelet Transfusion Thresholds: When to Transfuse and When Not to Transfuse – Chokri Ben Lamine
-
Jul 30, 2026, 14:34Flora Peyvandi: Genetics of Early-Onset Coronary Artery Disease in Iranians
-
Jul 30, 2026, 14:22Stéphanie Forté: New Evidence Strengthens the Case for Hydroxyurea in HbSC Disease
-
Jul 30, 2026, 14:09Hilal Ahmad: New Guidelines for Pediatric Ischemic Stroke Management